Related Experiment Video
Updated: May 28, 2026

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Published on: September 26, 2013
Interleukin-17, Interleukin-18, T Regulatory Cells, and T-Helper 17 (Th17) Cells Play a Role in Heart Failure: A
Sohat Sharma1, Jayant Seth1, Cameron J Leong1
1University of British Columbia, Vancouver, British Columbia, Canada, ubc.ca.
Background:
The objective of this study was to assess whether interleukin-17 or 18 (IL-17 or IL-18), regulatory T cells (Tregs), and T helper17 (Th17) serum concentrations were different in chronic heart failure not associated with myocarditis compared to healthy individuals.
Methods:
We searched MEDLINE and Embase for studies with data on IL-17 or IL-18 serum concentrations in patients with chronic heart failure. Forest plots were used to quantify results and depict the standard difference of means, 95% confidence interval (CI), and p value. Continuous outcomes were assessed as weighted mean differences (WMD) with their 95% CI.
Results:
IL-17 was significantly (p < 0.05) higher in patients with heart failure. The combined effect size under the random effects model (MD = 40.00 pg/mL, 95% CI [6.04, 73.96], p < 0.001) showed a significant overall increase in IL-17 serum levels in heart failure. Th17 was significantly (p < 0.05) higher in patients with heart failure, and Tregs are significantly lower compared to persons without heart failure. The random effects model indicates an MD of 1.59 pg/mL (95% CI [0.88, 2.30]), highlighting significant elevation of TH17 levels in heart failure. For Tregs, the random effects model presented an MD of -2.96 pg/mL (95% CI [-4.52, -1.40]), both indicating a significant decrease in Treg levels in HF. Additionally, serum IL-17 concentrations correlated with the severity of the reduction in LV ejection fraction. For IL-18, all (five) studies reported a statistically significant increase in IL-18 levels in HF. The pooled mean difference was 251.59 pg/mL (95% CI: 177.24-325.93 pg/mL) with a random effects model.
Conclusion:
Serum IL-17, IL-18 Th17, and Treg count have utility for risk stratification for patients with heart failure, as biomarkers for heart failure severity and potential target pathways for treatment.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Heart Failure IV: Classification and Diagnostic Evaluation

